Apatinib Combined with Temozolomide and Etoposide Capsules in the Treatment of Recurrent Medulloblastoma in Children
Clinical trial NCT04501718 · RECRUITING
Trial details
- NCT number
- NCT04501718
- Sponsor
- Beijing Sanbo Brain Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-28
- Primary completion
- 2025-08-31
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.